bioMérieux S.A. (BMXXY)
OTCMKTS · Delayed Price · Currency is USD
13.83
+0.88 (6.80%)
At close: Jul 11, 2025
Accolade Market Cap
bioMérieux has a market cap or net worth of $16.90 billion as of August 1, 2025. Its market cap has increased by 38.04% in one year.
Market Cap
16.90B
Enterprise Value
16.95B
Revenue
4.12B
Ranking
n/a
PE Ratio
37.76
Stock Price
$13.83
Market Cap Chart
Since July 7, 2004, bioMérieux's market cap has increased from 1.46B to 16.90B, an increase of 1,054.27%. That is a compound annual growth rate of 12.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 16.90B | 33.64% |
| Dec 31, 2024 | 12.64B | -3.73% |
| Dec 29, 2023 | 13.14B | 6.03% |
| Dec 30, 2022 | 12.39B | -26.30% |
| Dec 31, 2021 | 16.81B | 0.64% |
| Dec 31, 2020 | 16.70B | 58.81% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.80B |
| Veradigm | 823.67M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 519.96M |
| American Oncology Network | 408.39M |
| Glass House Brands | 396.28M |
| Northwest Biotherapeutics | 376.73M |
| Nika Pharmaceuticals | 366.89M |